Explore the previous trading day in detail.
Explore the previous trading day in detail.
Explore the selected trading day in detail.
Trading activity for the day was generally active, with regular session traded value increasing by +9.4% compared to the previous trading day, and traded value in the after-market and pre-market increasing by +23.4% and +9.7%, respectively.
INO's daily high was observed in the after-market at +251.13% compared to the previous day's closing price.
ABOS's daily low was observed in the regular session at -90.86% compared to the previous day's closing price (with a -85.66% fluctuation rate within the pre-market, which is a separate basis).
Amid the overall increase in traded value, some stocks showed significant fluctuations by session, indicating daily volatility.
A combined analysis of price, volume, and background is not ready yet.
On 2026, 10, 30, Inovio Pharmaceuticals (INO) announced that it received FDA accelerated approval for 'VOCERYQ,' a treatment for recurrent respiratory papillomatosis (RRP). This marks the first approval of a plasmid DNA-based immunotherapy in the United States. Following the announcement, an increase in price was observed during the same trading day.
This FDA accelerated approval is a significant regulatory achievement for Inovio as it transitions from the clinical stage to the commercialization stage. The resolution of previous regulatory uncertainty appears to have driven a positive reaction. However, since confirmatory studies are required under the accelerated approval conditions, long-term commercial success depends on additional clinical results and market penetration.
Preparing English content…
Preparing English content…
Preparing English content…
Preparing English content…
Preparing English content…
Preparing English content…
Regular trading value
Regular session traded value reached $4,050,000,000, an increase of +9.4% from the previous day. Among gainers, CHOW (+111.59%, $340,000,000) saw active trading, while among losers, PMN (-61.15%, $6,400,000) showed notable volatility.
We were unable to link the issues with confirmed announcement times and source evidence. The trading figure commentary above is provided based on verified aggregate data.
Times use ET and trading dates follow the U.S. market. Comparison prices and observation windows differ by ranking.
vs. previous regular close · overnight through after-hours
10/29, 20:00 – 10/30, 20:00 ET · Previous trading day 2026-10-29
Market cap $500M maximum 2,270eligible stocks out of 1,487종목을 비교합니다. 기준 종가 $0.10 이상·하루 거래대금 $100K 이상·유효 1분봉 5개 이상이 기준입니다. Compares official closing prices on the same share basis. Stocks are excluded on dates when splits or conversions change the comparison basis. Times refer to the first minute bar containing the high or low. The largest decline is not a peak-to-trough drawdown.
Price observations 358stocks · eligible for ranking 18종목 · 거래대금 $100K 이상
10/29, 20:00 – 10/30, 04:00 ET · Blue Ocean ATS
Included after market-cap verification 2,270stocks · unverified market caps excluded 978Stocks
Price observations 1,245stocks · eligible for ranking 89종목 · 거래대금 $100K 이상
10/30, 04:00 – 10/30, 09:30 ET · U.S. consolidated market data
Included after market-cap verification 2,270stocks · unverified market caps excluded 978Stocks
Price observations 2,249stocks · eligible for ranking 1,398종목 · 거래대금 $100K 이상
10/30, 09:30 – 10/30, 16:00 ET · U.S. consolidated market data
Included after market-cap verification 2,270stocks · unverified market caps excluded 978Stocks
Price observations 2,054stocks · eligible for ranking 120종목 · 거래대금 $100K 이상
10/30, 16:00 – 10/30, 20:00 ET · U.S. consolidated market data
Included after market-cap verification 2,270stocks · unverified market caps excluded 978Stocks
Requires prices in the first and last 30 minutes, at least five valid minute bars, and opening and closing prices of at least $0.10. Changes are measured from session open to close and may differ from changes against the previous trading-day close.
